
|Articles|August 11, 2008
FDA is warning that patients should receive genetic testing before obtaining Ziagen
FDA warns about AIDS drug, abacavir, due to increased risk of potentially fatal side effects for some patients.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Releases Biosimilar Guidance Pushing to Streamline Development
2
COVID-19 Vaccination Benefits Patients With Systemic Lupus Erythematosus
3
Q&A: Why Community Pharmacies are Displeased with the MDPNP | NCPA 2025
4
Pharmacies Should Prioritize Medicare Transaction Facilitator Enrollment | NCPA 2025
5




















































































































































